Back to Search
NIZAR TANNIR, M.D.
M.D.
Medical Oncology Physician
NPI: 1760588693IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
G7115(TX)
Education
OTHER
Class of 1979
Research & Publications (20)
A phase II trial of gemcitabine plus capecitabine for metastatic renal cell cancer previously treated with immunotherapy and targeted agents.
PMID 18635226·J Urol·2008
3-trial
Improved tolerability and quality of life with maintained efficacy using twice-daily low-dose interferon-alpha-2b: results of a randomized phase II trial of low-dose versus intermediate-dose interferon-alpha-2b in patients with metastatic renal cell carcinoma.
PMID 17029276·Cancer·2006
3-trial
Pilot trial of bone-targeted therapy with zoledronate, thalidomide, and interferon-gamma for metastatic renal cell carcinoma.
PMID 16795067·Cancer·2006
3-trial
Idiopathic thrombocytopenic purpura following successful treatment of acute lymphoblastic leukemia.
PMID 11342378·Leuk Lymphoma·2001
5-case
Acute pancreatitis associated with interferon alpha therapy for chronic myelogenous leukemia.
PMID 11342349·Leuk Lymphoma·2000
5-case
Cutaneous squamous cell carcinoma and inflammation of actinic keratoses associated with sorafenib.
PMID 19213663·Clin Genitourin Cancer·2009
8-other
Patterns of disease progression in metastatic renal cell carcinoma patients treated with antivascular agents and interferon: impact of therapy on recurrence patterns and outcome measures.
PMID 19241453·Cancer·2009
8-other
Phase II presurgical feasibility study of bevacizumab in untreated patients with metastatic renal cell carcinoma.
PMID 19636008·J Clin Oncol·2009
3-trial
Prospective assessment of systemic therapy followed by surgical removal of metastases in selected patients with renal cell carcinoma.
PMID 19338544·BJU Int·2009
8-other
LINE-1 methylation in plasma DNA as a biomarker of activity of DNA methylation inhibitors in patients with solid tumors.
PMID 19421002·Epigenetics·2009
8-other
Cytokines and angiogenic factors in patients with metastatic renal cell carcinoma treated with interferon-alpha: association of pretreatment serum levels with survival.
PMID 19541791·Ann Oncol·2009
8-other
Family history and risk of renal cell carcinoma: results from a case-control study and systematic meta-analysis.
PMID 19240244·Cancer Epidemiol Biomarkers Prev·2009
1-meta
Randomized trial of adjuvant thalidomide versus observation in patients with completely resected high-risk renal cell carcinoma.
PMID 18950837·Urology·2009
4-observational
Ischemic optic neuropathy associated with low-dose interferon alfa: report of two cases.
PMID 19194130·Am J Clin Oncol·2009
5-case
Long-term outcome for men with teratoma found at postchemotherapy retroperitoneal lymph node dissection.
PMID 19156903·Cancer·2009
4-observational
Choroidal and conjunctival metastases from renal cell carcinoma.
PMID 19657240·Am J Clin Oncol·2009
5-case
Genome-wide profiling of chromosomal alterations in renal cell carcinoma using high-density single nucleotide polymorphism arrays.
PMID 19521957·Int J Cancer·2009
4-observational
Renal cell carcinoma: diagnosis, staging, and surveillance.
PMID 18806169·AJR Am J Roentgenol·2008
6-review
Sunitinib-induced acute hemolysis without hypertension: a case report.
PMID 18824436·Clin Genitourin Cancer·2008
5-case
Multisystem crisis in a patient with presumptive renal cell carcinoma.
PMID 18824438·Clin Genitourin Cancer·2008
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1515 HOLCOMBE BLVD, 77030-4009
HOUSTON, TX 77030 - Phone
- (713) 792-6161
Quick Facts
- NPI
- 1760588693
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 47
- Publications
- 20
Are you this provider?
Claim Your Profile